FarmaKology Newsletter - Issue #26
Discover more from FarmaKology’s Substack
FarmaKology Newsletter - Issue #26
Today's Startup
twoXAR
twoXAR is a pharmaceutical company that has built a development portfolio targeting more than 18 different diseases. twoXAR’s unique approach to drug discovery combines steps from the traditional multi-step approach to R&D that severely limits the pace of drug discovery. This novel method – coupled with the company’s proprietary AI-driven platform – enables twoXAR to select a disease and initiate in vivo testing in months, instead of years.
News
Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
Sanofi and Synthorx, Inc., a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Synthorx for $68 per share in cash, which represents an aggregate equity value of approximately $2.5 billion (on a fully diluted basis).
Omnicell and Kit Check Partner to Offer Cloud-based Solution for Tracking of Controlled Substances
Omnicell, Inc., a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, has entered into an agreement with Kit Check™ to offer Bluesight™ for Controlled Substances diversion prevention software, helping customers to gain better visibility of controlled substances across the pharmacy supply chain.
Healx Joins Forces with Boehringer Ingelheim to Discover New Treatment Approaches for Rare Neurological Diseases
Healx Ltd., the AI-powered biotechnology company focused on developing breakthrough treatments for rare diseases, today announces it has entered into an agreement with Boehringer Ingelheim to identify indications related to rare neurological diseases.
WORLD’S FIRST MALE CONTRACEPTIVE INJECTION MAY SOON ARRIVE IN INDIA
The world's first male birth control injection is soon going to be launched by India. It is a long-lasting, non – hormonal contraceptive measure for men which will remain effective for 13 years. It will serve as an alternative to surgical vasectomy.
Research & Study
Immunotherapy drug improves outcomes for some children with relapsed leukemia
Common antibiotic appears to boost the effect of radiation on tumor cells
Secret behind diabetes drug's benefits revealed
Podcast
Job Opportunities
Medical Representative
Pharmacy Technician
clinical pharmacist
Pharmacist
Upcoming Events
The 2nd Saudi International Pharma Expo
Drug & Medical Device Litigation
Drug Delivery to the Lungs 2019
Video
